Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Comment by Bobo23on Jul 27, 2022 1:01pm
166 Views
Post# 34854178

RE:RE:RE:Comical Watching these buys...

RE:RE:RE:Comical Watching these buys...Way back when they did a study and the University of Rochester that was supposed to prove great effectiveness and sensitivity of their system...then the actual study did not seem to prove anything and they never talked about it again.  I assume the study failed since they did not seem to emphasize it at all.  Basically this appears to be a failed product and a very ineffective management team.  I expect they will run out of money soon then the creditors will get the IP assets.  I think they are probably waiting for that before they invest any more money because then they will own the tech 100%.  On the other hand who knows they never issue any shareholder updates...which is probably bad news in itself. In my opinion
<< Previous
Bullboard Posts
Next >>